๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
158 medicines starting with โ€œKโ€
MedicineActive substanceLicence holderStatus
Keflex 250 mg Hard Capsules
PA1226/002/001
Cefalexin Flynn Pharma Limited Marketed
Keflex 250 mg/5 ml Powder for Oral Suspension
PA1226/002/003
Cefalexin Flynn Pharma Limited Marketed
Keflex 500 mg Film-Coated Tablets
PA1226/002/004
Cefalexin Flynn Pharma Limited Marketed
Kelzy 2 mg/0.02 mg prolonged release tablets
PA22998/007/001
Dienogest, Ethinylestradiol Exeltis Healthcare S.L. Not marketed
Kemadrin 5 mg tablets
PPA0465/494/001
Procyclidine hydrochloride PCO Manufacturing Ltd. โ€”
Kemadrin 5 mg Tablets
PA1691/005/001
Procyclidine hydrochloride Aspen Pharma Trading Limited Marketed
Kengrexal 50 mg powder for concentrate for solution for injection/infusion
EU/1/15/994/001
Cangrelor tetrasodium Chiesi Farmaceutici S.p.A. โ€”
Kentera
EU/1/03/270/004-005
Oxybutynin hydrochloride Teva B.V. โ€”
Kentera 3.9 mg/24 hours transdermal patch
EU/1/03/270/1-2
Oxybutynin Teva B.V. โ€”
Keppra 100 mg/ml concentrate for solution for infusion
EU/1/00/146/033
Levetiracetam UCB Pharma S.A. โ€”
Keppra 100 mg/ml oral solution
EU/1/00/146/027
Levetiracetam UCB Pharma S.A. โ€”
Keppra 1000 mg film-coated tablets
EU/1/00/146/020-026
Levetiracetam UCB Pharma S.A. โ€”
Keppra 250 mg film-coated tablets
EU/1/00/146/001-005
Levetiracetam UCB Pharma S.A. โ€”
Keppra 500 mg film-coated tablets
EU/1/00/146/006-013
Levetiracetam UCB Pharma S.A. โ€”
Keppra 750 mg film-coated tablets
EU/1/00/146/014-019
Levetiracetam UCB Pharma S.A. โ€”
Keral 25 mg film-coated tablets
PA0865/002/002
Dexketoprofen Menarini International Operations Luxembourg S.A. Marketed
Keral 25 mg oral solution in sachet
PA0865/002/006
Dexketoprofen Menarini International Operations Luxembourg S.A. Not marketed
Keral 25mg granules for oral solution
PA0865/002/005
Dexketoprofen Menarini International Operations Luxembourg S.A. Not marketed
Keral 50 mg/2ml solution for injection/infusion
PA0865/002/003
Dexketoprofen trometamol Menarini International Operations Luxembourg S.A. Marketed
Kerendia 10 mg Film-coated tablet
EU/1/21/1616/001-005
Finerenone Bayer AG โ€”
Kerendia 20 mg Film-coated tablet
EU/1/21/1616/006-010
Finerenone Bayer AG โ€”
Kesimpta 20 mg solution for injection in pre-filled pen
EU/1/21/1532/003-004
Ofatumumab Novartis Europharm Limited โ€”
Kesimpta 20 mg solution for injection in pre-filled syringe
EU/1/21/1532/001-002
Ofatumumab Novartis Europharm Limited โ€”
Ketalar 10mg/ml Solution for Injection/Infusion
PA0822/013/001
Ketamine hydrochloride Pfizer Healthcare Ireland Unlimited Company Marketed
Ketalar 50 mg/ml Solution for Injection/Infusion
PA0822/013/002
Ketamine hydrochloride Pfizer Healthcare Ireland Unlimited Company Marketed
Ketoconazole 20mg/g Shampoo
PA0281/125/001
Ketoconazole Pinewood Laboratories Limited Marketed
Ketoconazole Esteve 200 mg tablets
EU/1/14/965/001
Ketoconazole Esteve Pharmaceuticals S.A. โ€”
Ketofall 0.25 mg/ml eye drops, solution in single-dose container
PA1815/002/001
Ketotifen hydrogen fumarate Pharma Stulln GmbH Marketed
Ketovite Liquid
PA23081/012/001
Ergocalciferol, Choline chloride, Cyanocobalamin, Vitamin A Taw Pharma (Ireland) Limited Not marketed
Kevzara 150 mg solution for injection in pre-filled syringe
EU/1/17/1196/001-002
Sarilumab Sanofi Winthrop Industrie โ€”
Kevzara 175 mg/ml solution for injection
EU/1/17/1196/013
Sarilumab Sanofi Winthrop Industrie โ€”
Kevzara 200 mg solution for injection in pre-filled syringe
EU/1/17/1196/003-008
Sarilumab Sanofi Winthrop Industrie โ€”
KEYTRUDA 25 mg/mL concentrate for solution for infusion
EU/1/15/1024/002
Pembrolizumab Merck Sharp & Dohme BV, โ€”
Kigabeq 100 mg Soluble tablet
EU/1/18/1302/001
Vigabatrin Orphelia Pharma SA โ€”
Kigabeq 500 mg Soluble tablet
EU/1/18/1302/002
Vigabatrin Orphelia Pharma SA โ€”
KIMMTRAK 100 micrograms/0.5 mL concentrate for solution for infusion
EU/1/22/1630/001
Tebentafusp Immunocore Ireland Limited โ€”
Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe
EU/1/02/203/005-007
Anakinra Swedish Orphan Biovitrum AB โ€”
Kinpeygo 4 mg modified-release hard capsules
EU/1/22/1657/001
Budesonide micronised Stada Arzneimittel AG โ€”
Kinzalkomb 40 mg/12.5 mg tablets
EU/1/02/214/1-5
Telmisartan, Hydrochlorothiazide Bayer AG โ€”
Kinzalkomb 80 mg/12.5 mg tablets
EU/1/02/214/006-010
Telmisartan, Hydrochlorothiazide Bayer AG โ€”
Kinzalkomb 80 mg/25 mg tablets
EU/1/02/214/11-15
Hydrochlorothiazide, Telmisartan Bayer AG โ€”
Kinzalmono 20 mg tablets
EU/1/98/091/009-012
Telmisartan Bayer AG โ€”
Kinzalmono 40 mg tablets
EU/1/98/091/001-004
Telmisartan Bayer AG โ€”
Kinzalmono 80 mg tablets
EU/1/98/091/005-008
Telmisartan Bayer AG โ€”
Kiovig 100 mg/ml solution for infusion
EU/1/05/329/001-006
Human normal immunoglobulin Baxter AG โ€”
Kirsty
EU/1/20/1506/001-007
Insulin aspart Biosimilar Collaborations Ireland Limited โ€”
Kisplyx 10 mg hard capsules
EU/1/16/1128/002
Lenvatinib mesilate Eisai GmbH โ€”
Kisplyx 4 mg hard capsules
EU/1/16/1128/001
Lenvatinib mesilate Eisai GmbH โ€”
Kisqali 200 mg film-coated tablets
EU/1/17/1221/001-012
Ribociclib Novartis Europharm Limited โ€”
Kisunla 350 mg concentrate for solution for infusion
EU/1/25/1926/001-002
Donanemab Eli Lilly Nederland B.V. โ€”
โ† 1 2 3 4 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.